Only EBUS-Guided Mediastinal Lymph Node Cryobiopsy Enabled Immunotherapy in a Patient with Non-Small Cell Lung Cancer

Personalized treatment of metastatic non-squamous non-small cell lung cancer (NSCLC) requires detailed molecular characterization of the tumour including detection of predictive driver mutations and programmed death ligand 1 (PD-L1) expression. Complete detection is influenced by the amount of tumou...

Descripción completa

Detalles Bibliográficos
Autores principales: Hetzel, Jürgen, Mauti, Laetitia A., Winkler, Jonas, Cardoso Almeida, Sabine, Jermann, Philip, Pless, Miklos, Bubendorf, Lukas, Bode, Peter Karl, Häntschel, Maik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051359/
https://www.ncbi.nlm.nih.gov/pubmed/36983354
http://dx.doi.org/10.3390/jcm12062355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051359/
https://www.ncbi.nlm.nih.gov/pubmed/36983354
http://dx.doi.org/10.3390/jcm12062355

Ejemplares similares